<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0135318</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-14803</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Polymorphisms of Osteopontin Promoter and Cancer Susceptibility</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Yulan</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Lei</surname>
<given-names>Hongbo</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Jixiang</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wang</surname>
<given-names>Jun</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Kui</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Dong</surname>
<given-names>Weiguo</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="cor001" ref-type="corresp">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Gao</surname>
<given-names>Jian-Xin</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Shanghai Jiao Tong University School of Medicine, CHINA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: YL WD. Performed the experiments: YL JZ WD. Analyzed the data: YL HL JW KL. Contributed reagents/materials/analysis tools: YL HL JZ. Wrote the paper: YL WD HL JW.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">dwg@whu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>8</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>8</issue>
<elocation-id>e0135318</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>4</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>7</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Liu et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0135318" xlink:type="simple"/>
<abstract>
<sec id="sec001">
<title>Background and Aim</title>
<p>Several studies have been conducted to examine the associations between osteopontin (OPN) promoter gene <italic>SPP1</italic> polymorphisms with human cancers in Chinese population, but the results remain inconsistent. The aim of this meta-analysis is to clarify the associations between <italic>SPP1</italic> polymorphisms and cancer susceptibility.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>All eligible case-control studies published up to March 2015 were identified by searching PubMed, Web of Science, Embase, and Cochrane Library without language restrictions. Pooled odds ratio (OR) and 95% confidence interval (95% CI) were calculated using fixed- or random-effect model.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>A total of 11 case-control studies were included; of those, there were eleven studies (3130 cases and 3828 controls) for -443T&gt;C polymorphism, ten studies (3019 cases and 3615 controls) for -156G&gt;GG polymorphism, eight studies (2258 cases and 2846 controls) for -66T&gt;G polymorphism. Overall, no evidence indicated that the -443 T&gt;C polymorphism was associated with cancer risk (OR = 0.93, 95%CI 0.62–1.38 for dominant model, OR = 1.06, 95%CI 0.73–1.55 for recessive model, OR = 0.88, 95%CI 0.62–1.26 for CT vs TT model, OR = 1.03, 95%CI 0.61–1.73 for CC vs TT model). While, a significantly increase risk was found for -156 G&gt;GG polymorphism (OR = 1.22, 95%CI 1.10–1.35 for dominant model, OR = 1.25, 95%CI 1.10–1.41 for recessive model, OR = 1.18, 95%CI 1.06–1.32 for GGG vs GG model, OR = 1.35, 95%CI 1.09–1.68 for GGGG vs GG model). For -66T&gt;G polymorphism, we found a decrease risk of cancer (OR = 0.84, 95% CI 0.71–0.98 for dominant model), but this result changed (OR = 0.93, 95% CI 0.77–1.12 for dominant model) when we excluded a study.</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>This meta-analysis suggests that in Chinese population the -156G&gt;GG polymorphism of <italic>SPP1</italic> might be a risk factor for human cancers, while -443T&gt;C mutation is not associated with cancer risk. For -66T&gt;G polymorphism, it may be a protective factor for human cancers.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>The authors have no support or funding to report.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="2"/>
<page-count count="12"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability" xlink:type="simple">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Cancers contribute a greatest deal to death worldwide [<xref rid="pone.0135318.ref001" ref-type="bibr">1</xref>], as a result of interactions between genetic mutation accumulation and environment risk factors. Genetic variation plays an important role in the tumorigenesis with the effect on gene structure and protein expression [<xref rid="pone.0135318.ref002" ref-type="bibr">2</xref>]. Several polymorphisms that have relationship with cancers in the human osteopontin (OPN) encoding gene <italic>SPP1</italic> have been searched.</p>
<p>OPN is a secreted glycophosphoprotein that may physiologically serve as a cytokine and an extracellular matrix molecule. It is expressed and secreted by various cells, and plays a role in bone remodeling, reconfiguration of tissue integrity during inflammatory processes, coronary restenosis, and cancer metastatic [<xref rid="pone.0135318.ref003" ref-type="bibr">3</xref>–<xref rid="pone.0135318.ref006" ref-type="bibr">6</xref>]. It has been demonstrated that OPN is associated with more than 30 cancers so far and a marker for breast, cervical, colorectal, head and neck, liver, lung, ovarian and prostate cancers, as well as for sarcoma [<xref rid="pone.0135318.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0135318.ref008" ref-type="bibr">8</xref>]. The tight correlation with tumor metastatic and progression was initially reported in 1979 [<xref rid="pone.0135318.ref009" ref-type="bibr">9</xref>] and had been approved by many studies, however, the association between OPN and carcinogenesis has just been researched recently [<xref rid="pone.0135318.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0135318.ref011" ref-type="bibr">11</xref>]. The expression of OPN was significantly influenced by its genetic polymorphisms of the promoter [<xref rid="pone.0135318.ref012" ref-type="bibr">12</xref>], <italic>SPP1</italic> (mapped to chromosome 4q24-q25), which is predominantly a transcriptionally regulated gene with highly conserved promoter [<xref rid="pone.0135318.ref013" ref-type="bibr">13</xref>]. Several polymorphisms in the <italic>SPP1</italic> gene affect OPN expression and the level of its secretion into bovine milk [<xref rid="pone.0135318.ref014" ref-type="bibr">14</xref>]. Common single nucleotide polymorphisms (SNPs) such as -443C&gt;T (rs11730582), -156G&gt;GG (rs17524488) and -66T&gt;G (rs28357094) may result in increased expression of <italic>SPP1</italic> gene and tumor risk. The results remain inconclusive and a comprehensive analysis is necessary. Therefore, we implemented a meta-analysis that integrated all studies for <italic>SPP1</italic>polymorphisms and risk for all types of human cancer in order to obtain an accurate assessment.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec007">
<title>Search strategy</title>
<p>A literature research was conducted using PubMed, Web of Science, Embase, and Cochrane Library up to March 2015 without language restrictions. Relevant studies were searched using the terms [osteopontin or OPN or <italic>SPP1</italic>] AND [-443C&gt;T or rs11730582 or -156G&gt;GG or rs17524488 or -66T&gt;G or rs28357094] AND [variant or genetic polymorphism or polymorphism or mutation]. Additional studies were identified by screening references in the retrieved articles and preceding reviews on the topic.</p>
</sec>
<sec id="sec008">
<title>Inclusion criteria and exclusion criteria</title>
<p>Studies were included if they met the following criteria: (1) case–control study; (2) about the associations between <italic>SPP1</italic> polymorphisms (-443T&gt;C or -156G&gt;GG or -66T&gt;G) and cancer risks; and (3) had available genotype frequencies of cases and controls or could be calculated from the paper. Accordingly, the exclusion criteria were (1) duplicate data, (2) only for cancer samples, (3) only for benign disease compared with controls, and (4) number of the cases less than 30.</p>
</sec>
<sec id="sec009">
<title>Data extraction and quality assessment</title>
<p>Two of the authors independently selected the article and extracted data with consensus on all of the terms. If the data was not identical, the two investigators would check the data again to come to an agreement. If they could not reach an agreement, an expert (Weiguo Dong) would participate in the discussion. Following items were collected from the eligible articles: first author’s name, year of publication, country of origin, ethnicity, cancer type, number of cases and controls, age, gender, OPN levels and genotypes distributions in cases and controls.</p>
<p>The quality of selected studies was independently evaluated on basis of Newcastle-Ottawa scale (NOS) [<xref rid="pone.0135318.ref015" ref-type="bibr">15</xref>]. Studies with six or more stars were considered as high quality.</p>
</sec>
<sec id="sec010">
<title>Statistical analysis</title>
<p>Meta-analysis was performed using the Cochrane Collaboration Revman 5.3 (Copenhagen, 2014) and STATS package version 9.2 (Stata corporation, College Station, Texas). The risk of cancer associated with three polymorphisms respectively of <italic>SPP1</italic> gene was estimated for each eligible study by odds ratio (OR) and 95% confidence interval (95% CI). We used χ<sup>2</sup>-based Q statistic text [<xref rid="pone.0135318.ref016" ref-type="bibr">16</xref>] and <italic>I</italic><sup><italic>2</italic></sup> index [<xref rid="pone.0135318.ref017" ref-type="bibr">17</xref>] to assess the heterogeneity between the studies. When heterogeneity across studies (Q test P≤0.05 or <italic>I</italic><sup><italic>2</italic></sup> &gt;50%) was showed, random-effect model was used [<xref rid="pone.0135318.ref018" ref-type="bibr">18</xref>], otherwise, the fixed-effects model was used [<xref rid="pone.0135318.ref019" ref-type="bibr">19</xref>]. Hardy-Weinberg equilibrium (HWE) in control people was judged by χ<sup>2</sup> text. We evaluated the associations of three polymorphisms with cancer risk under dominant, recessive, codominant, and heterozygote models respectively. Then, we analyzed the sensitivity to evaluate the stability of results after removing the studies deviating from HWE. Publication bias was diagnosed with Begg’s funnel plot [<xref rid="pone.0135318.ref020" ref-type="bibr">20</xref>] and Egger’s linear regression [<xref rid="pone.0135318.ref021" ref-type="bibr">21</xref>]. P&lt;0.05 was regarded as a state of disequilibrium.</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<sec id="sec012">
<title>Study characteristics</title>
<p>The search strategy retrieved 40 potential relevant studies and one study was identified through references. According to the inclusion and exclusion criteria, 11 studies [<xref rid="pone.0135318.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0135318.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0135318.ref022" ref-type="bibr">22</xref>–<xref rid="pone.0135318.ref030" ref-type="bibr">30</xref>]with full text were eligible for this meta-analysis and 30 studies were excluded. The flow chart of study selection is summarized in <xref rid="pone.0135318.g001" ref-type="fig">Fig 1</xref>. All studies taken in China and all participators came from Chinese population. There were eleven case-control studies with 3130 cancer cases and 3828 controls concerning -443T&gt;C polymorphism, ten case-control studies with 3019 cases and 3615 controls concerning -156 G&gt;GG, and eight case-control studies with 2258 cases and 2846 controls concerning -66T&gt;G. Cancer types include glioma, non-small-cell lung cancer (NSCLC), oral squamous cell carcinoma (OSCC), gastric cancer (GC), papillary thyroid cancer (PTC), nasopharyngeal carcinoma (NPC), cervical cancer, acute myeloid leukemia (AML), and intrahepatic cholangiocarcinoma (ICC). Blood samples were used to determine genetic polymorphisms in all of the included studies. The distribution of genotypes in the controls was consistent with HWE for all selected studies except for two studies [<xref rid="pone.0135318.ref023" ref-type="bibr">23</xref>,<xref rid="pone.0135318.ref029" ref-type="bibr">29</xref>]. The qualities of all included studies were categorized as high quality. <xref rid="pone.0135318.t001" ref-type="table">Table 1</xref> showed the characteristics and NOS quality of the enrolled studies.</p>
<fig id="pone.0135318.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0135318.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow chart showing study selection procedure.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0135318.g001" position="float" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0135318.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0135318.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of studies included in the meta-analysis.</title></caption>
<alternatives>
<graphic id="pone.0135318.t001g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0135318.t001" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Study</th>
<th align="left" rowspan="1" colspan="1">Year</th>
<th align="left" rowspan="1" colspan="1">Cancer type</th>
<th align="left" rowspan="1" colspan="1">Number</th>
<th colspan="2" align="left" rowspan="1">Age, mean ± SD, year</th>
<th align="left" rowspan="1" colspan="1">Gender (male, %)</th>
<th colspan="3" align="center" rowspan="1">Genotype (case/control)</th>
<th align="left" rowspan="1" colspan="1">P<sub>HWE</sub></th>
<th align="left" rowspan="1" colspan="1">NOS</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1"/>
<th align="left" rowspan="1" colspan="1"/>
<th align="left" rowspan="1" colspan="1"/>
<th align="left" rowspan="1" colspan="1">Case/Control</th>
<th align="left" rowspan="1" colspan="1">Case</th>
<th align="left" rowspan="1" colspan="1">Control</th>
<th align="left" rowspan="1" colspan="1">Case/Control</th>
<th align="left" rowspan="1" colspan="1">WT Ho</th>
<th align="left" rowspan="1" colspan="1">Ht</th>
<th align="left" rowspan="1" colspan="1">VR Ho</th>
<th align="left" rowspan="1" colspan="1"/>
<th align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">-443T&gt;C</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Chen JX</td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Glioma</td>
<td align="left" rowspan="1" colspan="1">670 /680</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">59.7/54.6</td>
<td align="left" rowspan="1" colspan="1">299/284</td>
<td align="left" rowspan="1" colspan="1">299/311</td>
<td align="left" rowspan="1" colspan="1">69/77</td>
<td align="left" rowspan="1" colspan="1">0.557</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Chen YZ</td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">NSCLC</td>
<td align="left" rowspan="1" colspan="1">360/360</td>
<td align="left" rowspan="1" colspan="1">57.2</td>
<td align="left" rowspan="1" colspan="1">56.3</td>
<td align="left" rowspan="1" colspan="1">55.3/54.7</td>
<td align="left" rowspan="1" colspan="1">164/153</td>
<td align="left" rowspan="1" colspan="1">165/163</td>
<td align="left" rowspan="1" colspan="1">31/44</td>
<td align="left" rowspan="1" colspan="1">0.954</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Chiu YW</td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">OSCC</td>
<td align="left" rowspan="1" colspan="1">97/100</td>
<td align="left" rowspan="1" colspan="1">53.6</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">88.7/NR</td>
<td align="left" rowspan="1" colspan="1">47/33</td>
<td align="left" rowspan="1" colspan="1">41/50</td>
<td align="left" rowspan="1" colspan="1">9/17</td>
<td align="left" rowspan="1" colspan="1">0.793</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Lee TY</td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">GC</td>
<td align="left" rowspan="1" colspan="1">146/128</td>
<td align="left" rowspan="1" colspan="1">64.0±13.9</td>
<td align="left" rowspan="1" colspan="1">61.4±8.5</td>
<td align="left" rowspan="1" colspan="1">59.6/57.0</td>
<td align="left" rowspan="1" colspan="1">59/65</td>
<td align="left" rowspan="1" colspan="1">66/55</td>
<td align="left" rowspan="1" colspan="1">21/8</td>
<td align="left" rowspan="1" colspan="1">0.416</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Mu GY</td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">PTC</td>
<td align="left" rowspan="1" colspan="1">363/413</td>
<td align="left" rowspan="1" colspan="1">38.6±2.1</td>
<td align="left" rowspan="1" colspan="1">38.4±4.3</td>
<td align="left" rowspan="1" colspan="1">39.4/49.4</td>
<td align="left" rowspan="1" colspan="1">73/164</td>
<td align="left" rowspan="1" colspan="1">171/187</td>
<td align="left" rowspan="1" colspan="1">119/62</td>
<td align="left" rowspan="1" colspan="1">0.469</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Shen ZP</td>
<td align="left" rowspan="1" colspan="1">2014</td>
<td align="left" rowspan="1" colspan="1">Glioma</td>
<td align="left" rowspan="1" colspan="1">248/281</td>
<td align="left" rowspan="1" colspan="1">45.2±3.5</td>
<td align="left" rowspan="1" colspan="1">44.9±4.1</td>
<td align="left" rowspan="1" colspan="1">46.7/45.7</td>
<td align="left" rowspan="1" colspan="1">54/90</td>
<td align="left" rowspan="1" colspan="1">113/137</td>
<td align="left" rowspan="1" colspan="1">81/54</td>
<td align="left" rowspan="1" colspan="1">0.885</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Wang JL</td>
<td align="left" rowspan="1" colspan="1">2014</td>
<td align="left" rowspan="1" colspan="1">NPC</td>
<td align="left" rowspan="1" colspan="1">108/210</td>
<td align="left" rowspan="1" colspan="1">48.2±10.5</td>
<td align="left" rowspan="1" colspan="1">47.8±11.2</td>
<td align="left" rowspan="1" colspan="1">66.7/57.1</td>
<td align="left" rowspan="1" colspan="1">60/85</td>
<td align="left" rowspan="1" colspan="1">38/95</td>
<td align="left" rowspan="1" colspan="1">10/30</td>
<td align="left" rowspan="1" colspan="1">0.678</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Xu Q</td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Cervical cancer</td>
<td align="left" rowspan="1" colspan="1">300/774</td>
<td align="left" rowspan="1" colspan="1">54.6±5.7</td>
<td align="left" rowspan="1" colspan="1">54.5±2.6</td>
<td align="left" rowspan="1" colspan="1">0/0</td>
<td align="left" rowspan="1" colspan="1">227/343</td>
<td align="left" rowspan="1" colspan="1">49/334</td>
<td align="left" rowspan="1" colspan="1">24/106</td>
<td align="left" rowspan="1" colspan="1">0.126</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Zhang R</td>
<td align="left" rowspan="1" colspan="1">2015</td>
<td align="left" rowspan="1" colspan="1">AML</td>
<td align="left" rowspan="1" colspan="1">381/430</td>
<td align="left" rowspan="1" colspan="1">54.5±3.6</td>
<td align="left" rowspan="1" colspan="1">54.6±4.1</td>
<td align="left" rowspan="1" colspan="1">51.7/52.1</td>
<td align="left" rowspan="1" colspan="1">81/117</td>
<td align="left" rowspan="1" colspan="1">183/223</td>
<td align="left" rowspan="1" colspan="1">117/90</td>
<td align="left" rowspan="1" colspan="1">0.392</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Zhao FJ</td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">GC</td>
<td align="left" rowspan="1" colspan="1">200/200</td>
<td align="left" rowspan="1" colspan="1">56.3±3.5</td>
<td align="left" rowspan="1" colspan="1">55.7±4.2</td>
<td align="left" rowspan="1" colspan="1">65.0/65.0</td>
<td align="left" rowspan="1" colspan="1">91/85</td>
<td align="left" rowspan="1" colspan="1">94/93</td>
<td align="left" rowspan="1" colspan="1">15/22</td>
<td align="left" rowspan="1" colspan="1">0.646</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Zhao XQ</td>
<td align="left" rowspan="1" colspan="1">2014</td>
<td align="left" rowspan="1" colspan="1">ICC</td>
<td align="left" rowspan="1" colspan="1">260/260</td>
<td align="left" rowspan="1" colspan="1">57.2±NR</td>
<td align="left" rowspan="1" colspan="1">56.3±NR</td>
<td align="left" rowspan="1" colspan="1">57.3/56.5</td>
<td align="left" rowspan="1" colspan="1">120/114</td>
<td align="left" rowspan="1" colspan="1">111/115</td>
<td align="left" rowspan="1" colspan="1">29/31</td>
<td align="left" rowspan="1" colspan="1">0.809</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-156G&gt;GG</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Chen JX</td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Glioma</td>
<td align="left" rowspan="1" colspan="1">670 /680</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">59.7/54.6</td>
<td align="left" rowspan="1" colspan="1">220/273</td>
<td align="left" rowspan="1" colspan="1">345/306</td>
<td align="left" rowspan="1" colspan="1">99/90</td>
<td align="left" rowspan="1" colspan="1">0.772</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Chen YZ</td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">NSCLC</td>
<td align="left" rowspan="1" colspan="1">360/360</td>
<td align="left" rowspan="1" colspan="1">57.2</td>
<td align="left" rowspan="1" colspan="1">56.3</td>
<td align="left" rowspan="1" colspan="1">55.3/54.7</td>
<td align="left" rowspan="1" colspan="1">137/155</td>
<td align="left" rowspan="1" colspan="1">150/136</td>
<td align="left" rowspan="1" colspan="1">73/69</td>
<td align="left" rowspan="1" colspan="1">0.0001</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Chiu YW</td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">OSCC</td>
<td align="left" rowspan="1" colspan="1">97/100</td>
<td align="left" rowspan="1" colspan="1">53.6</td>
<td align="left" rowspan="1" colspan="1">NR</td>
<td align="left" rowspan="1" colspan="1">88.7/NR</td>
<td align="left" rowspan="1" colspan="1">27/42</td>
<td align="left" rowspan="1" colspan="1">52/49</td>
<td align="left" rowspan="1" colspan="1">18/9</td>
<td align="left" rowspan="1" colspan="1">0.318</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Lee TY</td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">GC</td>
<td align="left" rowspan="1" colspan="1">146/128</td>
<td align="left" rowspan="1" colspan="1">64.0±13.9</td>
<td align="left" rowspan="1" colspan="1">61.4±8.5</td>
<td align="left" rowspan="1" colspan="1">59.6/57.0</td>
<td align="left" rowspan="1" colspan="1">48/46</td>
<td align="left" rowspan="1" colspan="1">72/64</td>
<td align="left" rowspan="1" colspan="1">26/18</td>
<td align="left" rowspan="1" colspan="1">0.911</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Mu GY</td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">PTC</td>
<td align="left" rowspan="1" colspan="1">363/413</td>
<td align="left" rowspan="1" colspan="1">38.6±2.1</td>
<td align="left" rowspan="1" colspan="1">38.4±4.3</td>
<td align="left" rowspan="1" colspan="1">39.4/49.4</td>
<td align="left" rowspan="1" colspan="1">104/100</td>
<td align="left" rowspan="1" colspan="1">187/219</td>
<td align="left" rowspan="1" colspan="1">72/94</td>
<td align="left" rowspan="1" colspan="1">0.217</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Shen ZP</td>
<td align="left" rowspan="1" colspan="1">2014</td>
<td align="left" rowspan="1" colspan="1">Glioma</td>
<td align="left" rowspan="1" colspan="1">248/281</td>
<td align="left" rowspan="1" colspan="1">45.2±3.5</td>
<td align="left" rowspan="1" colspan="1">44.9±4.1</td>
<td align="left" rowspan="1" colspan="1">46.7/45.7</td>
<td align="left" rowspan="1" colspan="1">57/67</td>
<td align="left" rowspan="1" colspan="1">124/153</td>
<td align="left" rowspan="1" colspan="1">67/61</td>
<td align="left" rowspan="1" colspan="1">0.134</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Xu Q</td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Cervical cancer</td>
<td align="left" rowspan="1" colspan="1">300/774</td>
<td align="left" rowspan="1" colspan="1">54.6±5.7</td>
<td align="left" rowspan="1" colspan="1">54.5±2.6</td>
<td align="left" rowspan="1" colspan="1">0/0</td>
<td align="left" rowspan="1" colspan="1">88/287</td>
<td align="left" rowspan="1" colspan="1">129/359</td>
<td align="left" rowspan="1" colspan="1">83/128</td>
<td align="left" rowspan="1" colspan="1">0.318</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Zhang R</td>
<td align="left" rowspan="1" colspan="1">2015</td>
<td align="left" rowspan="1" colspan="1">AML</td>
<td align="left" rowspan="1" colspan="1">381/430</td>
<td align="left" rowspan="1" colspan="1">54.5±3.6</td>
<td align="left" rowspan="1" colspan="1">54.6±4.1</td>
<td align="left" rowspan="1" colspan="1">51.7/52.1</td>
<td align="left" rowspan="1" colspan="1">84/114</td>
<td align="left" rowspan="1" colspan="1">198/226</td>
<td align="left" rowspan="1" colspan="1">99/90</td>
<td align="left" rowspan="1" colspan="1">0.259</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Zhao FJ</td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">GC</td>
<td align="left" rowspan="1" colspan="1">200/200</td>
<td align="left" rowspan="1" colspan="1">56.3±3.5</td>
<td align="left" rowspan="1" colspan="1">55.7±4.2</td>
<td align="left" rowspan="1" colspan="1">65.0/65.0</td>
<td align="left" rowspan="1" colspan="1">67/86</td>
<td align="left" rowspan="1" colspan="1">92/78</td>
<td align="left" rowspan="1" colspan="1">41/36</td>
<td align="left" rowspan="1" colspan="1">0.017</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Zhao XQ</td>
<td align="left" rowspan="1" colspan="1">2014</td>
<td align="left" rowspan="1" colspan="1">ICC</td>
<td align="left" rowspan="1" colspan="1">260/260</td>
<td align="left" rowspan="1" colspan="1">57.2±NR</td>
<td align="left" rowspan="1" colspan="1">56.3±NR</td>
<td align="left" rowspan="1" colspan="1">57.3/56.5</td>
<td align="left" rowspan="1" colspan="1">111/107</td>
<td align="left" rowspan="1" colspan="1">101/110</td>
<td align="left" rowspan="1" colspan="1">48/43</td>
<td align="left" rowspan="1" colspan="1">0.109</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-66T&gt;G</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Chen YZ</td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">NSCLC</td>
<td align="left" rowspan="1" colspan="1">360/360</td>
<td align="left" rowspan="1" colspan="1">57.2</td>
<td align="left" rowspan="1" colspan="1">56.3</td>
<td align="left" rowspan="1" colspan="1">55.3/54.7</td>
<td align="left" rowspan="1" colspan="1">356/351</td>
<td align="left" rowspan="1" colspan="1">4/9</td>
<td align="left" rowspan="1" colspan="1">0/0</td>
<td align="left" rowspan="1" colspan="1">0.81</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Lee TY</td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">GC</td>
<td align="left" rowspan="1" colspan="1">146/128</td>
<td align="left" rowspan="1" colspan="1">64.0±13.9</td>
<td align="left" rowspan="1" colspan="1">61.4±8.5</td>
<td align="left" rowspan="1" colspan="1">59.6/57.0</td>
<td align="left" rowspan="1" colspan="1">146/128</td>
<td align="left" rowspan="1" colspan="1">0/0</td>
<td align="left" rowspan="1" colspan="1">0/0</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Mu GY</td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">PTC</td>
<td align="left" rowspan="1" colspan="1">363/413</td>
<td align="left" rowspan="1" colspan="1">38.6±2.1</td>
<td align="left" rowspan="1" colspan="1">38.4±4.3</td>
<td align="left" rowspan="1" colspan="1">39.4/49.4</td>
<td align="left" rowspan="1" colspan="1">99/114</td>
<td align="left" rowspan="1" colspan="1">167/191</td>
<td align="left" rowspan="1" colspan="1">97/108</td>
<td align="left" rowspan="1" colspan="1">0.128</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Shen ZP</td>
<td align="left" rowspan="1" colspan="1">2014</td>
<td align="left" rowspan="1" colspan="1">Glioma</td>
<td align="left" rowspan="1" colspan="1">248/281</td>
<td align="left" rowspan="1" colspan="1">45.2±3.5</td>
<td align="left" rowspan="1" colspan="1">44.9±4.1</td>
<td align="left" rowspan="1" colspan="1">46.7/45.7</td>
<td align="left" rowspan="1" colspan="1">83/88</td>
<td align="left" rowspan="1" colspan="1">130/147</td>
<td align="left" rowspan="1" colspan="1">35/46</td>
<td align="left" rowspan="1" colspan="1">0.239</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Xu Q</td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Cervical cancer</td>
<td align="left" rowspan="1" colspan="1">300/774</td>
<td align="left" rowspan="1" colspan="1">54.6±5.7</td>
<td align="left" rowspan="1" colspan="1">54.5±2.6</td>
<td align="left" rowspan="1" colspan="1">0/0</td>
<td align="left" rowspan="1" colspan="1">97/181</td>
<td align="left" rowspan="1" colspan="1">199/210</td>
<td align="left" rowspan="1" colspan="1">93/121</td>
<td align="left" rowspan="1" colspan="1">0.668</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Zhang R</td>
<td align="left" rowspan="1" colspan="1">2015</td>
<td align="left" rowspan="1" colspan="1">AML</td>
<td align="left" rowspan="1" colspan="1">381/430</td>
<td align="left" rowspan="1" colspan="1">54.5±3.6</td>
<td align="left" rowspan="1" colspan="1">54.6±4.1</td>
<td align="left" rowspan="1" colspan="1">51.7/52.1</td>
<td align="left" rowspan="1" colspan="1">89/99</td>
<td align="left" rowspan="1" colspan="1">199/210</td>
<td align="left" rowspan="1" colspan="1">93/121</td>
<td align="left" rowspan="1" colspan="1">0.668</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Zhao FJ</td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">GC</td>
<td align="left" rowspan="1" colspan="1">200/200</td>
<td align="left" rowspan="1" colspan="1">56.3±3.5</td>
<td align="left" rowspan="1" colspan="1">55.7±4.2</td>
<td align="left" rowspan="1" colspan="1">65.0/65.0</td>
<td align="left" rowspan="1" colspan="1">200/200</td>
<td align="left" rowspan="1" colspan="1">0/0</td>
<td align="left" rowspan="1" colspan="1">0/0</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Zhao XQ</td>
<td align="left" rowspan="1" colspan="1">2014</td>
<td align="left" rowspan="1" colspan="1">ICC</td>
<td align="left" rowspan="1" colspan="1">260/260</td>
<td align="left" rowspan="1" colspan="1">57.2±NR</td>
<td align="left" rowspan="1" colspan="1">56.3±NR</td>
<td align="left" rowspan="1" colspan="1">57.3/56.5</td>
<td align="left" rowspan="1" colspan="1">256/251</td>
<td align="left" rowspan="1" colspan="1">4/9</td>
<td align="left" rowspan="1" colspan="1">0/0</td>
<td align="left" rowspan="1" colspan="1">0.776</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>P<sub>HWE</sub> was calculated by goodness-of fit χ<sup>2</sup>-test, P<sub>HWE</sub> &lt;0.05 was considered statistically significant; Ht, heterozygote; HWE, Hardy–Weinberg equilibrium; NA, not available; VR Ho, variant homozygote; WT Ho, wild-type homozygote.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec013">
<title>Quantitative data synthesis</title>
<p>For -443T&gt;C polymorphism, eleven case-control studies [<xref rid="pone.0135318.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0135318.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0135318.ref022" ref-type="bibr">22</xref>–<xref rid="pone.0135318.ref030" ref-type="bibr">30</xref>] with 3130 cases and 3828 controls were identified. Overall, there is no significant difference in -443T&gt;C genotype distribution between cancer and control [dominant model (OR = 0.93, 95%CI 0.62–1.38, <italic>P</italic>&lt;0.0001); recessive model (OR = 1.06, 95%CI 0.73–1.55, <italic>P</italic>&lt;0.0001); CT vs TT model (OR = 0.88, 95%CI 0.62–1.26, <italic>P</italic>&lt;0.0001); CC vs TT model (OR = 1.03, 95%CI 0.61–1.73, <italic>P</italic>&lt;0.0001)] (<xref rid="pone.0135318.t002" ref-type="table">Table 2</xref>).</p>
<table-wrap id="pone.0135318.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0135318.t002</object-id>
<label>Table 2</label> <caption><title>Summary of ORs of the <italic>SPP1</italic> polymorphisms and cancer risk.</title></caption>
<alternatives>
<graphic id="pone.0135318.t002g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0135318.t002" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">SNP</th>
<th align="left" rowspan="1" colspan="1">n</th>
<th colspan="3" align="left" rowspan="1">Dominant model</th>
<th colspan="3" align="left" rowspan="1">Recessive model</th>
<th colspan="3" align="left" rowspan="1">Ht versus WT Ho</th>
<th colspan="3" align="left" rowspan="1">VR Ho versus WT Ho</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1"/>
<th align="left" rowspan="1" colspan="1"/>
<th align="left" rowspan="1" colspan="1">OR(95% CI)</th>
<th align="left" rowspan="1" colspan="1">P<xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref></th>
<th align="left" rowspan="1" colspan="1">I<sup>2</sup></th>
<th align="left" rowspan="1" colspan="1">OR(95% CI)</th>
<th align="left" rowspan="1" colspan="1">P</th>
<th align="left" rowspan="1" colspan="1">I<sup>2</sup></th>
<th align="left" rowspan="1" colspan="1">OR(95% CI)</th>
<th align="left" rowspan="1" colspan="1">P</th>
<th align="left" rowspan="1" colspan="1">I<sup>2</sup></th>
<th align="left" rowspan="1" colspan="1">OR(95% CI)</th>
<th align="left" rowspan="1" colspan="1">P</th>
<th align="left" rowspan="1" colspan="1">I<sup>2</sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">-443T/C</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">0.93(0.62,1.38)</td>
<td align="char" char="." rowspan="1" colspan="1">.000</td>
<td align="left" rowspan="1" colspan="1">93%</td>
<td align="left" rowspan="1" colspan="1">1.06(0.73,1.55)</td>
<td align="char" char="." rowspan="1" colspan="1">.000</td>
<td align="left" rowspan="1" colspan="1">85%</td>
<td align="left" rowspan="1" colspan="1">0.88(0.62,1.26)</td>
<td align="char" char="." rowspan="1" colspan="1">.000</td>
<td align="left" rowspan="1" colspan="1">90%</td>
<td align="left" rowspan="1" colspan="1">1.03(0.61,1.73)</td>
<td align="char" char="." rowspan="1" colspan="1">.000</td>
<td align="left" rowspan="1" colspan="1">91%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-156G/GG</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Total</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">1.22(1.10,1.35)</td>
<td align="char" char="." rowspan="1" colspan="1">.09</td>
<td align="left" rowspan="1" colspan="1">40%<xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">1.25(1.10,1.41)</td>
<td align="char" char="." rowspan="1" colspan="1">.07</td>
<td align="left" rowspan="1" colspan="1">43%<xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">1.18(1.06,1.32)</td>
<td align="char" char="." rowspan="1" colspan="1">.15</td>
<td align="left" rowspan="1" colspan="1">32%<xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">1.35(1.09,1.68)</td>
<td align="char" char="." rowspan="1" colspan="1">.03</td>
<td align="left" rowspan="1" colspan="1">52%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Studies with HWE</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">1.20(1.07,1.35)</td>
<td align="char" char="." rowspan="1" colspan="1">0.05</td>
<td align="left" rowspan="1" colspan="1">50%<xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">1.29(1.05,1.60)</td>
<td align="char" char="." rowspan="1" colspan="1">.07</td>
<td align="left" rowspan="1" colspan="1">53%</td>
<td align="left" rowspan="1" colspan="1">1.13(1.00,1.28)</td>
<td align="char" char="." rowspan="1" colspan="1">0.16</td>
<td align="left" rowspan="1" colspan="1">33%<xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">1.37(1.05,1.80)</td>
<td align="char" char="." rowspan="1" colspan="1">0.01</td>
<td align="left" rowspan="1" colspan="1">62%</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-66T/G</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.84(0.71,0.98)</td>
<td align="char" char="." rowspan="1" colspan="1">.15</td>
<td align="left" rowspan="1" colspan="1">38%<xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">1.02(0.79,1.32)</td>
<td align="char" char="." rowspan="1" colspan="1">.07</td>
<td align="left" rowspan="1" colspan="1">57%</td>
<td align="left" rowspan="1" colspan="1">0.76(0.54,1.08)</td>
<td align="char" char="." rowspan="1" colspan="1">.006</td>
<td align="left" rowspan="1" colspan="1">70%</td>
<td align="left" rowspan="1" colspan="1">0.91(0.74,1.10)</td>
<td align="char" char="." rowspan="1" colspan="1">.87<xref rid="t002fn003" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>n: number of studies.</p></fn>
<fn id="t002fn002"><p><sup>a</sup>Test for heterogeneity.</p></fn>
<fn id="t002fn003"><p><sup>b</sup>Fixed-effect model was used when the P for heterogeneity test was&gt;0.05 or I<sup>2</sup>≤50%, otherwise the random-effect model was used.</p></fn>
<fn id="t002fn004"><p>CI, confidence interval; OR, odds ratio; SNP, single-nucleotide polymorphism; Ht+VR Ho vs WT Ho, dominant model; VR Ho vs Ht+WT Ho, recessive model.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>For -156G&gt;GG polymorphism, ten case-control studies [<xref rid="pone.0135318.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0135318.ref022" ref-type="bibr">22</xref>–<xref rid="pone.0135318.ref030" ref-type="bibr">30</xref>] with 3019 cases and 3615 controls were identified. Overall, a significant increased risk was found under all four models [dominant model (OR = 1.22, 95%CI 1.10–1.35, <italic>P</italic> = 0.09); recessive model (OR = 1.25, 95%CI 1.10–1.41, <italic>P</italic> = 0.07); GGG vs GG model (OR = 1.18, 95%CI 1.06–1.32, <italic>P</italic> = 0.15); GGGG vs GG model (OR = 1.35, 95%CI 1.09–1.68, <italic>P</italic> = 0.03)] (<xref rid="pone.0135318.t002" ref-type="table">Table 2</xref>). We evaluated the influence of these studies on the pooled OR by deleting the studies that were not in HWE from the meta-analysis. The estimated pooled odd ratio still did not change at all (<xref rid="pone.0135318.t002" ref-type="table">Table 2</xref>).</p>
<p>For -66T&gt;G polymorphism, eight case-control studies [<xref rid="pone.0135318.ref023" ref-type="bibr">23</xref>–<xref rid="pone.0135318.ref030" ref-type="bibr">30</xref>] with 2258 cases and 2846 controls were identified. Overall, we found that a significant decreased risk under dominant model (OR = 0.84, 95%CI 0.71–0.98, <italic>P</italic> = 0.15), but no significant association was found under other three models (<xref rid="pone.0135318.t002" ref-type="table">Table 2</xref>).</p>
</sec>
<sec id="sec014">
<title>Heterogeneity and sensitivity analysis</title>
<p>For -443T&gt;C polymorphism, there was significant heterogeneity for overall comparisons under all four models (<italic>P</italic>&lt;0.0001). For -156G&gt;GG polymorphism, significant heterogeneity between studies was observed in overall comparisons under GG/GG versus GG model (<italic>I</italic><sup>2</sup> = 52%, <italic>P</italic> = 0.03). And for -66T&gt;G polymorphism, significant heterogeneity between studies was found in overall comparisons under recessive model and TG versus TT model (<italic>I</italic><sup><italic>2</italic></sup> = 57%, <italic>P</italic> = 0.07; <italic>I</italic><sup><italic>2</italic></sup> = 0.006, <italic>P</italic> = 70%, respectively). (<xref rid="pone.0135318.g002" ref-type="fig">Fig 2</xref>). Then, sensitivity analysis was performed to evaluate the stability of the results by removing one study one by one. For -156G&gt;GG polymorphism, the heterogeneity decreased when exclude the study by Mu GY, so it suggests that Mu GY may be the source of heterogeneity. For -66 T&gt;G polymorphism, the heterogeneity decreased to zero when the study of Xu Q were excluded, so the particular study may be the source of heterogeneity.</p>
<fig id="pone.0135318.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0135318.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Meta-analysis of the association between <italic>SPP1</italic> polymorphisms and susceptibility to cancer under dominant model.</title>
<p>(a) -443 T&gt;C. (b) -156G&gt;GG. (c)-156G&gt;GG with HWE. (d) -66T&gt;G.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0135318.g002" position="float" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec015">
<title>Publication bias</title>
<p>Begg’s funnel plot and Egger’s test were performed to address potential publication bias in the available literature. The shape of funnel plots did not indicate any evidence of funnel plot asymmetry (<xref rid="pone.0135318.g003" ref-type="fig">Fig 3</xref>). Egger’s test also reveal that there was no statistical significance for evaluation of publication bias under dominant model (-443T&gt;C: <italic>P</italic> = 0.818, -156G&gt;GG: <italic>P</italic> = 0.418, -66T&gt;G: <italic>P</italic> = 0.842).</p>
<fig id="pone.0135318.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0135318.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Begg’s funnel plot for publication bias under dominant model.</title>
<p>(a) -443T&gt;G. (b) -156G&gt;GG. (c) −66T&gt;G</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0135318.g003" position="float" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec016" sec-type="conclusions">
<title>Discussion</title>
<p>Osteopontin is a member of small intrgrin-binding ligand N-linked glycoproteins (SIBLINGs) family. There are many pieces of evidences indicating that osteopontin profoundly regulate the development and progression of various tumors. Additionally, OPN expression was significantly higher in human cancers tissues than in matched normal tissues and it was significantly associated with nodal metastasis and more advanced clinical stage. Therefore, numerous publications have tested OPN as a biomarker for cancer invasiveness [<xref rid="pone.0135318.ref031" ref-type="bibr">31</xref>–<xref rid="pone.0135318.ref034" ref-type="bibr">34</xref>]. However, the associations with tumorigenesis have not been proved well. Polymorphisms in the OPN gene, <italic>SPP1</italic>, may potentially alter the expression of OPN and then modulate the risk for cancer. In recent years, SNPs have been identified as a powerful tool for predicting some complex diseases. However, previous genetic epidemiological studies about the associations between OPN gene polymorphisms and the risk of human cancer are limited, and the results were inconclusive. To our knowledge, this is the first meta-analysis which investigated the possible correlations of rs11730582 (-443 T&gt;C), rs17524488 (-156G&gt;GG), and rs28357094 (-66T&gt;G) polymorphisms in the <italic>SPP1</italic> gene with cancer susceptibility.</p>
<p>Our results revealed that -443T&gt;C polymorphism might have no relation with pathogenesis of cancer. And we found that different studies had inconsistent results about this polymorphism even for the same cancer. For example, Chen JX [<xref rid="pone.0135318.ref022" ref-type="bibr">22</xref>] said that in a recessive genetic model TC + CC genotypes significantly decrease the risk of glioma when compared with TT, but Shen ZP [<xref rid="pone.0135318.ref026" ref-type="bibr">26</xref>] considered that the glioma patients had markedly high frequency of -443CC genotype than controls. Another two studies [<xref rid="pone.0135318.ref029" ref-type="bibr">29</xref>,<xref rid="pone.0135318.ref030" ref-type="bibr">30</xref>] showed that there was no significant difference in the distribution of -443 between cancer patients and controls. What’s more, large heterogeneity was found in four gene models (P&lt;0.0001). Previous meta-analysis about human cancer risk found that the cancer type might contribute most to the source of heterogeneity [<xref rid="pone.0135318.ref035" ref-type="bibr">35</xref>,<xref rid="pone.0135318.ref036" ref-type="bibr">36</xref>]. In this study, the subgroup analysis on basis of cancer types was not calculated because of the limited number of studies. So this result should be interpreted with caution.</p>
<p>For -156G&gt;GG, our study found that GG allele was at significant high risk for cancer under all four genetic models, and this result was confirmed among studies in HWE. When we exclude the study of Mu GY [<xref rid="pone.0135318.ref025" ref-type="bibr">25</xref>] which may be source of the heterogeneity, the results remain unchanged. That means the SNP of -156G&gt;GG may considerably act a potential candidate of biomarker for cancer risk.</p>
<p>The meta-analysis of -66T&gt;G include eight studies, however, two studies [<xref rid="pone.0135318.ref024" ref-type="bibr">24</xref>,<xref rid="pone.0135318.ref029" ref-type="bibr">29</xref>] that was not estimable in meta-analysis (<xref rid="pone.0135318.g002" ref-type="fig">Fig 2</xref>). The results of polymorphism in a dominant model showed that the genotypes TG+ GG significantly decreased the risk of cancer when compared with TT. Noteworthy, the association was disappear when exclude the study of Xu Q [<xref rid="pone.0135318.ref027" ref-type="bibr">27</xref>] that may be the source of the heterogeneity. So, the result is instable and further studies are necessary to clarify the association.</p>
<p>High OPN expression in the primary tumors is associated with cancer risk, metastasis and poor clinical outcome [<xref rid="pone.0135318.ref037" ref-type="bibr">37</xref>–<xref rid="pone.0135318.ref039" ref-type="bibr">39</xref>]. The previous study showed that -443 promoter region exerts influence on OPN gene expression in melanoma cells [<xref rid="pone.0135318.ref040" ref-type="bibr">40</xref>]. In our including studies, four studies [<xref rid="pone.0135318.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0135318.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0135318.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0135318.ref028" ref-type="bibr">28</xref>] observed the association of OPN levels and <italic>SPP1</italic> polymorphisms. Mu GY [<xref rid="pone.0135318.ref025" ref-type="bibr">25</xref>] and Zhang R [<xref rid="pone.0135318.ref028" ref-type="bibr">28</xref>] observed that the high OPN expression was more frequent in samples from -443 CC carriers than TT carriers, However, Shen ZP [<xref rid="pone.0135318.ref026" ref-type="bibr">26</xref>] found that none of the polymorphisms affected the serum OPN levels, Wang JL [<xref rid="pone.0135318.ref010" ref-type="bibr">10</xref>] thought that carriers of CC and CT genotype of -443 presented lower serum osteopontin levels than those of TT genotype. Among the four studies only two gave the accurate data, so we cannot offer further statistics. The result may be caused by following reasons: (1) the <italic>SPP1</italic> polymorphisms affected the tumor OPN expression level, but not the serum OPN level; (2) the association is indeed related and further studies are just needed; (3) <italic>SPP1</italic> polymorphisms make no difference in OPN level.</p>
<p>Some advantage could be highlighted in this meta-analysis. On one hand, this research shed lights on the relationship of genetic polymorphisms in <italic>SPP1</italic> gene and the increased susceptibility to human cancers in Chinese population systematically. One the other hand, the exhaustive inclusion criteria and articles on wide range of cancers enhanced the power and persuasion of our conclusion. Furthermore, all literatures included had acceptable quality scores (scored at least 6). Meanwhile, we were also aware of several limitations of our study. First, all eligible studies come from China and the patients are Chinese population. Second, the number of the studies, especially for -66T&gt;G polymorphism, was not sufficiently large, Third, for -443T&gt;C polymorphism, the heterogeneity was big, the comprehensive analysis should be explain with caution.</p>
</sec>
<sec id="sec017" sec-type="conclusions">
<title>Conclusions</title>
<p>This meta-analysis indicated that in Chinese population the -156G&gt;GG polymorphism of <italic>SPP1</italic> may increase the susceptibility of human cancers, while -443T&gt;C mutation is not associated with cancer risk. For -66T&gt;G polymorphism, it may be a protective factor for human cancers. Accordingly, large and well-designed studies are warranted to validate our findings. The populations in this study only came from China. Thus, populations of other ethnicities should be involved in future studies.</p>
</sec>
<sec id="sec018">
<title>Supporting Information</title>
<supplementary-material id="pone.0135318.s001" xlink:href="info:doi/10.1371/journal.pone.0135318.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:type="simple">
<label>S1 Checklist</label>
<caption>
<title>Meta-analysis on Genetic Association Studies checklist.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0135318.s002" xlink:href="info:doi/10.1371/journal.pone.0135318.s002" mimetype="application/msword" position="float" xlink:type="simple">
<label>S1 Checklist</label>
<caption>
<title>PRISMA Checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0135318.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Torre</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Bray</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Siegel</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Ferlay</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lortet-Tieulent</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Jemal</surname> <given-names>A</given-names></name> (<year>2015</year>) <article-title>Global cancer statistics, 2012</article-title>. <source>CA Cancer J Clin</source> <volume>65</volume>: <fpage>87</fpage>–<lpage>108</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3322/caac.21262" xlink:type="simple">10.3322/caac.21262</ext-link></comment> <object-id pub-id-type="pmid">25651787</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hudson</surname> <given-names>TJ</given-names></name> (<year>2013</year>) <article-title>Genome variation and personalized cancer medicine</article-title>. <source>J Intern Med</source> <volume>274</volume>: <fpage>440</fpage>–<lpage>450</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/joim.12097" xlink:type="simple">10.1111/joim.12097</ext-link></comment> <object-id pub-id-type="pmid">23751076</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stepien</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Wypasek</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Stopyra</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Konieczynska</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Przybylo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pasowicz</surname> <given-names>M</given-names></name> (<year>2011</year>) <article-title>Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals</article-title>. <source>Clin Biochem</source> <volume>44</volume>: <fpage>826</fpage>–<lpage>831</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.clinbiochem.2011.04.016" xlink:type="simple">10.1016/j.clinbiochem.2011.04.016</ext-link></comment> <object-id pub-id-type="pmid">21539822</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kato</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Momiyama</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ohmori</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Tanaka</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Taniguchi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Arakawa</surname> <given-names>K</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention</article-title>. <source>Circ J</source> <volume>73</volume>: <fpage>152</fpage>–<lpage>157</lpage>. <object-id pub-id-type="pmid">19023151</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rangaswami</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Bulbule</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kundu</surname> <given-names>GC</given-names></name> (<year>2006</year>) <article-title>Osteopontin: role in cell signaling and cancer progression</article-title>. <source>Trends Cell Biol</source> <volume>16</volume>: <fpage>79</fpage>–<lpage>87</lpage>. <object-id pub-id-type="pmid">16406521</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Irita</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Okura</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Jotoku</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nagao</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Enomoto</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kurata</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney</article-title>. <source>Am J Physiol Renal Physiol</source> <volume>301</volume>: <fpage>F833</fpage>–<lpage>F844</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/ajprenal.00557.2010" xlink:type="simple">10.1152/ajprenal.00557.2010</ext-link></comment> <object-id pub-id-type="pmid">21734100</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weber</surname> <given-names>GF</given-names></name>, <name name-style="western"><surname>Lett</surname> <given-names>GS</given-names></name>, <name name-style="western"><surname>Haubein</surname> <given-names>NC</given-names></name> (<year>2011</year>) <article-title>Categorical meta-analysis of Osteopontin as a clinical cancer marker</article-title>. <source>Oncol Rep</source> <volume>25</volume>: <fpage>433</fpage>–<lpage>441</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3892/or.2010.1106" xlink:type="simple">10.3892/or.2010.1106</ext-link></comment> <object-id pub-id-type="pmid">21165579</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weber</surname> <given-names>GF</given-names></name>, <name name-style="western"><surname>Lett</surname> <given-names>GS</given-names></name>, <name name-style="western"><surname>Haubein</surname> <given-names>NC</given-names></name> (<year>2010</year>) <article-title>Osteopontin is a marker for cancer aggressiveness and patient survival</article-title>. <source>Br J Cancer</source> <volume>103</volume>: <fpage>861</fpage>–<lpage>869</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/sj.bjc.6605834" xlink:type="simple">10.1038/sj.bjc.6605834</ext-link></comment> <object-id pub-id-type="pmid">20823889</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Senger</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Wirth</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>Hynes</surname> <given-names>RO</given-names></name> (<year>1979</year>) <article-title>Transformed mammalian cells secrete specific proteins and phosphoproteins</article-title>. <source>Cell</source> <volume>16</volume>: <fpage>885</fpage>–<lpage>893</lpage>. <object-id pub-id-type="pmid">88265</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Nong</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>YS</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>FL</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>CF</given-names></name> (<year>2014</year>) <article-title>Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma</article-title>. <source>Med Oncol</source> <volume>31</volume>: <fpage>20</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s12032-014-0020-x" xlink:type="simple">10.1007/s12032-014-0020-x</ext-link></comment> <object-id pub-id-type="pmid">24913806</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fan</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>ZH</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>XW</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>SN</given-names></name>, <name name-style="western"><surname>Zhong</surname> <given-names>L</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma</article-title>. <source>DNA Cell Biol</source> <volume>32</volume>: <fpage>594</fpage>–<lpage>600</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/dna.2013.2090" xlink:type="simple">10.1089/dna.2013.2090</ext-link></comment> <object-id pub-id-type="pmid">23952692</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chiu</surname> <given-names>YW</given-names></name>, <name name-style="western"><surname>Tu</surname> <given-names>HF</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>IK</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>KW</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>TY</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis</article-title>. <source>Oral Oncol</source> <volume>46</volume>: <fpage>302</fpage>–<lpage>306</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.oraloncology.2010.01.018" xlink:type="simple">10.1016/j.oraloncology.2010.01.018</ext-link></comment> <object-id pub-id-type="pmid">20219412</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hijiya</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Setoguchi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Matsuura</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Higuchi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Akizuki</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yamamoto</surname> <given-names>S</given-names></name> (<year>1994</year>) <article-title>Cloning and characterization of the human osteopontin gene and its promoter</article-title>. <source>Biochem J</source> <volume>303</volume> (<issue>Pt 1</issue>): <fpage>255</fpage>–<lpage>262</lpage>. <object-id pub-id-type="pmid">7945249</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dudemaine</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Thibault</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Alain</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Bissonnette</surname> <given-names>N</given-names></name> (<year>2014</year>) <article-title>Genetic variations in the SPP1 promoter affect gene expression and the level of osteopontin secretion into bovine milk</article-title>. <source>Anim Genet</source> <volume>45</volume>: <fpage>629</fpage>–<lpage>640</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/age.12176" xlink:type="simple">10.1111/age.12176</ext-link></comment> <object-id pub-id-type="pmid">24961487</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stang</surname> <given-names>A</given-names></name> (<year>2010</year>) <article-title>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</article-title>. <source>Eur J Epidemiol</source> <volume>25</volume>: <fpage>603</fpage>–<lpage>605</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10654-010-9491-z" xlink:type="simple">10.1007/s10654-010-9491-z</ext-link></comment> <object-id pub-id-type="pmid">20652370</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name> (<year>2002</year>) <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source> <volume>21</volume>: <fpage>1539</fpage>–<lpage>1558</lpage>. <object-id pub-id-type="pmid">12111919</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>. <object-id pub-id-type="pmid">12958120</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname> <given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>. <object-id pub-id-type="pmid">3802833</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mantel</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Haenszel</surname> <given-names>W</given-names></name> (<year>1959</year>) <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J Natl Cancer Inst</source> <volume>22</volume>: <fpage>719</fpage>–<lpage>748</lpage>. <object-id pub-id-type="pmid">13655060</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davey</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ribas</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>SPP1 promoter polymorphisms and glioma risk in a Chinese Han population</article-title>. <source>J Hum Genet</source> <volume>55</volume>: <fpage>456</fpage>–<lpage>461</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jhg.2010.48" xlink:type="simple">10.1038/jhg.2010.48</ext-link></comment> <object-id pub-id-type="pmid">20505679</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name> (<year>2013</year>) <article-title>Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis</article-title>. <source>J Exp Clin Cancer Res</source> <volume>32</volume>: <fpage>45</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1756-9966-32-45" xlink:type="simple">10.1186/1756-9966-32-45</ext-link></comment> <object-id pub-id-type="pmid">23883434</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>TY</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>TC</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer</article-title>. <source>J Clin Gastroenterol</source> <volume>47</volume>: <fpage>e55</fpage>–<lpage>e59</lpage>. <object-id pub-id-type="pmid">23426449</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mu</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Cai</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Ji</surname> <given-names>H</given-names></name> (<year>2013</year>) <article-title>OPN -443C&gt;T genetic polymorphism and tumor OPN expression are associated with the risk and clinical features of papillary thyroid cancer in a Chinese cohort</article-title>. <source>Cell Physiol Biochem</source> <volume>32</volume>: <fpage>171</fpage>–<lpage>179</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000350133" xlink:type="simple">10.1159/000350133</ext-link></comment> <object-id pub-id-type="pmid">23867349</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shen</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hou</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Fan</surname> <given-names>J</given-names></name> (<year>2014</year>) <article-title>Polymorphism -433 C&gt;T of the Osteopontin gene is associated with the susceptibility to develop gliomas and their prognosis in a Chinese cohort</article-title>. <source>Cell Physiol Biochem</source> <volume>34</volume>: <fpage>1190</fpage>–<lpage>1198</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000366331" xlink:type="simple">10.1159/000366331</ext-link></comment> <object-id pub-id-type="pmid">25277531</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Yuan</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Xue</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>H</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>OPN gene polymorphisms are associated with susceptibility and clinicopatholigical characteristics of cervical cancer in a Chinese cohort</article-title>. <source>Cancer Biomark</source> <volume>10</volume>: <fpage>233</fpage>–<lpage>239</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3233/CBM-2012-0251" xlink:type="simple">10.3233/CBM-2012-0251</ext-link></comment> <object-id pub-id-type="pmid">22699784</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>Yao</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>R</given-names></name>, <etal>et al</etal>. (<year>2015</year>) <article-title>The OPN gene polymorphism confers the susceptibility and response to Ara-C based chemotherapy in Chinese AML patients</article-title>. <source>Cell Physiol Biochem</source> <volume>35</volume>: <fpage>175</fpage>–<lpage>183</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000369685" xlink:type="simple">10.1159/000369685</ext-link></comment> <object-id pub-id-type="pmid">25591760</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Meng</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hao</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>G</given-names></name> (<year>2012</year>) <article-title>Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer</article-title>. <source>BMC Cancer</source> <volume>12</volume>: <fpage>477</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2407-12-477" xlink:type="simple">10.1186/1471-2407-12-477</ext-link></comment> <object-id pub-id-type="pmid">23072570</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname> <given-names>XQ</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>HX</given-names></name>, <name name-style="western"><surname>Su</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>L</given-names></name> (<year>2014</year>) <article-title>Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population</article-title>. <source>Int J Clin Exp Pathol</source> <volume>7</volume>: <fpage>6914</fpage>–<lpage>6921</lpage>. <object-id pub-id-type="pmid">25400775</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mirza</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shaughnessy</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Hurley</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Vanpatten</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Pestano</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>B</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Osteopontin-c is a selective marker of breast cancer</article-title>. <source>Int J Cancer</source> <volume>122</volume>: <fpage>889</fpage>–<lpage>897</lpage>. <object-id pub-id-type="pmid">17960616</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Chiang</surname> <given-names>EP</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>CJ</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Elevated plasma osteopontin associated with gastric cancer development, invasion and survival</article-title>. <source>Gut</source> <volume>56</volume>: <fpage>782</fpage>–<lpage>789</lpage>. <object-id pub-id-type="pmid">17148500</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname> <given-names>YS</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ahn</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>SK</given-names></name> (<year>2007</year>) <article-title>Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer</article-title>. <source>Lung Cancer</source> <volume>57</volume>: <fpage>373</fpage>–<lpage>380</lpage>. <object-id pub-id-type="pmid">17513004</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hashiguchi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Tsuda</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Bandera</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Nishimura</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Inoue</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kawamura</surname> <given-names>N</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer</article-title>. <source>Med Oncol</source> <volume>23</volume>: <fpage>205</fpage>–<lpage>212</lpage>. <object-id pub-id-type="pmid">16720920</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Tong</surname> <given-names>N</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies</article-title>. <source>PLoS One</source> <volume>6</volume>: <fpage>e18108</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0018108" xlink:type="simple">10.1371/journal.pone.0018108</ext-link></comment> <object-id pub-id-type="pmid">21483822</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Yuan</surname> <given-names>Y</given-names></name> (<year>2013</year>) <article-title>Pre-miR-27a rs895819A/G polymorphisms in cancer: a meta-analysis</article-title>. <source>PLoS One</source> <volume>8</volume>: <fpage>e65208</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0065208" xlink:type="simple">10.1371/journal.pone.0065208</ext-link></comment> <object-id pub-id-type="pmid">23762318</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alain</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Karrow</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Thibault</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>St-Pierre</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lessard</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bissonnette</surname> <given-names>N</given-names></name> (<year>2009</year>) <article-title>Osteopontin: an early innate immune marker of Escherichia coli mastitis harbors genetic polymorphisms with possible links with resistance to mastitis</article-title>. <source>BMC Genomics</source> <volume>10</volume>: <fpage>444</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2164-10-444" xlink:type="simple">10.1186/1471-2164-10-444</ext-link></comment> <object-id pub-id-type="pmid">19765294</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hou</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>52</volume>: <fpage>7084</fpage>–<lpage>7089</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1167/iovs.11-7539" xlink:type="simple">10.1167/iovs.11-7539</ext-link></comment> <object-id pub-id-type="pmid">21810982</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramchandani</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Weber</surname> <given-names>GF</given-names></name> (<year>2013</year>) <article-title>An osteopontin promoter polymorphism is associated with aggressiveness in breast cancer</article-title>. <source>Oncol Rep</source> <volume>30</volume>: <fpage>1860</fpage>–<lpage>1868</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3892/or.2013.2632" xlink:type="simple">10.3892/or.2013.2632</ext-link></comment> <object-id pub-id-type="pmid">23900428</object-id></mixed-citation></ref>
<ref id="pone.0135318.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schultz</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lorenz</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Ibrahim</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Kundt</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gross</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kunz</surname> <given-names>M</given-names></name> (<year>2009</year>) <article-title>The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor</article-title>. <source>Mol Carcinog</source> <volume>48</volume>: <fpage>14</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/mc.20452" xlink:type="simple">10.1002/mc.20452</ext-link></comment> <object-id pub-id-type="pmid">18459127</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>